Nanomaterials in tumor immunotherapy: new strategies and challenges

Bibliographic Details
Title: Nanomaterials in tumor immunotherapy: new strategies and challenges
Authors: Xudong Zhu, Shenglong Li
Source: Molecular Cancer, Vol 22, Iss 1, Pp 1-28 (2023)
Publisher Information: BMC, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Nanomaterials, Tumor immunotherapy, Poly lactic-co-glycolic acid, Hydrogel nanoparticles, Liposomes, Lipid nanoparticles, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Tumor immunotherapy exerts its anti-tumor effects by stimulating and enhancing immune responses of the body. It has become another important modality of anti-tumor therapy with significant clinical efficacy and advantages compared to chemotherapy, radiotherapy and targeted therapy. Although various kinds of tumor immunotherapeutic drugs have emerged, the challenges faced in the delivery of these drugs, such as poor tumor permeability and low tumor cell uptake rate, had prevented their widespread application. Recently, nanomaterials had emerged as a means for treatment of different diseases due to their targeting properties, biocompatibility and functionalities. Moreover, nanomaterials possess various characteristics that overcome the defects of traditional tumor immunotherapy, such as large drug loading capacity, precise tumor targeting and easy modification, thus leading to their wide application in tumor immunotherapy. There are two main classes of novel nanoparticles mentioned in this review: organic (polymeric nanomaterials, liposomes and lipid nanoparticles) and inorganic (non-metallic nanomaterials and metallic nanomaterials). Besides, the fabrication method for nanoparticles, Nanoemulsions, was also introduced. In summary, this review article mainly discussed the research progress of tumor immunotherapy based on nanomaterials in the past few years and offers a theoretical basis for exploring novel tumor immunotherapy strategies in the future.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1476-4598
Relation: https://doaj.org/toc/1476-4598
DOI: 10.1186/s12943-023-01797-9
Access URL: https://doaj.org/article/a3010f418baf4da484610b1ece939017
Accession Number: edsdoj.3010f418baf4da484610b1ece939017
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14764598
DOI:10.1186/s12943-023-01797-9
Published in:Molecular Cancer
Language:English